TheProfitWatch

BDTX - Black Diamond Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.88 0.31 (7.99%) --- --- 0.03 (0.72%) -0.08 (-2.06%) 0.31 (8.08%) 0.05 (1.21%) 0.05 (1.21%)

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.19
Diluted EPS:
-0.19
Basic P/E:
-22.0526
Diluted P/E:
-22.0526
RSI(14) 1m:
100.0
VWAP:
4.19
RVol:
0.8143

Events

Period Kind Movement Occurred At
1m Price increase 1m 4.17 +0.04 (+1.09%) Oct 15 15:52
1m Price increase 1m 3.88 +0.05 (+1.31%) Oct 15 09:31

Related News